浙江医药股份有限公司关于持股5%以上股东集中竞价减持股份计划公告

Group 1 - The major shareholder, Guotou High-Tech Investment Co., Ltd., holds 150,127,573 shares, accounting for 15.61% of the total share capital of Zhejiang Medicine Co., Ltd. [2] - Guotou High-Tech plans to reduce its holdings by no more than 9,616,377 shares, which is up to 1% of the total share capital, within three months after the announcement date [3] - The reduction plan will be adjusted in case of any corporate actions such as dividend distribution or capital increase during the reduction period [3] Group 2 - There are no concerted actions among the shareholders involved in the reduction plan [4] - The actual start of the reduction may be postponed if the company's stock is suspended during the pre-disclosure period [5] - The reduction plan complies with relevant laws and regulations, and the company will continue to monitor the progress of the reduction plan [8]